Platelet-activating factor receptor

被引:120
|
作者
Ishii, S
Nagase, T
Shimizu, T
机构
[1] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan
[2] Univ Tokyo, Fac Med, Dept Geriatr Med, Bunkyo Ku, Tokyo 1130033, Japan
[3] Japan Sci & Technol Corp, CREST, Bunkyo Ku, Tokyo 1130033, Japan
关键词
platelet-activating factor; phospholipid mediator; intracellular signaling pathways;
D O I
10.1016/S0090-6980(02)00058-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a biologically active phospholipid mediator. Although PAF was named for its potential to induce platelet aggregation, intense investigations have elucidated potent biological actions of PAF in a broad range of cell types and tissues. PAF acts by binding to a unique G-protein-coupled seven transmembrane receptor, and activates multiple intracellular signaling pathways. In the last decade, we have identified the PAF receptor structures, intracellular signaling mechanisms, and genomic organizations. Recently, we found a single nucleotide polymorphism of the human PAF receptor (A224D) with an allele frequency of 7.8% in Japanese. Cells expressing this receptor exhibited the reduced cellular signaling, although the binding parameters remain unchanged. We have established two different types of genetically altered mice, i.e. PAF receptor-overexpressing mouse and PAF receptor-deficient mouse. These mutant mice provide a novel and specific approach for identifying the pathophysiological and physiological functions of PAF in vivo. This review focuses on phenotypes of these mutant mice and summarizes the previous reports regarding PAF and PAF receptor. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:599 / 609
页数:11
相关论文
共 50 条
  • [1] Platelet-activating factor receptor
    Honda, Z
    Ishii, S
    Shimizu, T
    JOURNAL OF BIOCHEMISTRY, 2002, 131 (06) : 773 - 779
  • [2] Platelet-Activating Factor and Pain
    Tsuda, Makoto
    Tozaki-Saitoh, Hidetoshi
    Inoue, Kazuhide
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (08) : 1159 - 1162
  • [3] Embryonic Platelet-Activating Factor: Temporal Expression of the Ligand and Receptor
    William E. Roudebush
    Elissa T. Purnell
    Neil R. Stoddart
    Steven D. Fleming
    Journal of Assisted Reproduction and Genetics, 2002, 19 : 72 - 78
  • [4] A novel receptor for platelet-activating factor and lysophosphatidylcholine in Trypanosoma cruzi
    Coelho, Felipe S.
    Oliveira, Mauricio M.
    Vieira, Danielle P.
    Torres, Pedro H. M.
    Moreira, Isabel C. F.
    Martins-Duarte, Erica S.
    Goncalves, Ines C.
    Cabanelas, Adriana
    Pascutti, Pedro G.
    Fragoso, Stenio P.
    Lopes, Angela H.
    MOLECULAR MICROBIOLOGY, 2021, 116 (03) : 890 - 908
  • [6] Therapy for acute pancreatitis with platelet-activating factor receptor antagonists
    Chen, Chong
    Xia, Shi-Hai
    Chen, Hong
    Li, Xiao-Hong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (30) : 4735 - 4738
  • [7] Immunofluorescent evidence of the platelet-activating factor receptor on human spermatozoa
    Reinhardt, JC
    Cui, XY
    Roudelbush, WE
    FERTILITY AND STERILITY, 1999, 71 (05) : 941 - 942
  • [8] Embryonic platelet-activating factor: Temporal expression of the ligand and receptor
    Roudebush, WE
    Purnell, ET
    Stoddart, NR
    Fleming, SD
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2002, 19 (02) : 72 - 78
  • [9] Mammalian platelet-activating factor acetylhydrolases
    Stafforini, DM
    Prescott, SM
    Zimmerman, GA
    McIntyre, TM
    BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1301 (03): : 161 - 173
  • [10] Platelet-activating factor and human meningiomas
    Denizot, Y.
    De Armas, R.
    Caire, F.
    Pommepuy, I.
    Truffinet, V.
    Labrousse, F.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2006, 32 (06) : 674 - 678